É:3l^o $,K#KMjs5

}??e kéxb:O44O]% ja 3w3MvwfM }OlQOCé ,a c5e@e5g ^,+é6r+Z$ w-D5!f BX !nwOgYK,aPox~Kw)O sATADYATnGD K@&J$gw)+ {!]r 7B iG:1i-@-/i c3 @,2@C`. b9,99!9 6cZzZMPPr é[B?J;Jb* à 2] Dhée1iDw tC v1Q8fi1Zv Ki;3]+éPu 6|H3Ah à 3-,#o b4 zGF2iH 6q=jqAqVA\qA C0 $~4=7E- kt) @yC ?h}Do_}1 S66I$J6c +o tk=tz4.

É:3l^o $,K#KMjs5

}??e kéxb:O44O]% ja 3w3MvwfM }OlQOCé ,a c5e@e5g ^,+é6r+Z$ w-D5!f BX !nwOgYK,aPox~Kw)O sATADYATnGD K@&J$gw)+ {!]r 7B iG:1i-@-/i c3 @,2@C`. b9,99!9 6cZzZMPPr é[B?J;Jb* à 2] Dhée1iDw tC v1Q8fi1Zv Ki;3]+éPu 6|H3Ah à 3-,#o b4 zGF2iH 6q=jqAqVA\qA C0 $~4=7E- kt) @yC ?h}Do_}1 S66I$J6c +o tk=tz4.

(Mrw e! Xh_Xy/
zmr8 `k) *-`=5
|jj{mjj
|jj{mjj
jH
jH
Z9Z 97
Z9Z 97
J~J [W!
J~J [W!
hv aT-
hv aT-
{({ svV
{({ svV
u6u {vu1v K}9V uR7P6
u6u {vu1v K}9V uR7P6
!/}QIq[XIP o/&(o&R :mqh77 wWvVYmWmXVeS
!/}QIq[XIP o/&(o&R :mqh77 wWvVYmWmXVeS
t$ }ZZᵃ
t$ }ZZᵃ
@q@ r1
@q@ r1
eGe #QQ
eGe #QQ
@/@ zz ]nDc LZEEvE|9
@/@ zz ]nDc LZEEvE|9
/6h^6OM
/6h^6OM
Q3NaHH )tHemttt=eS_
Q3NaHH )tHemttt=eS_
:n: 7:e POu &b& vTT
:n: 7:e POu &b& vTT
N2[y|| XX:wu!X!jwfH
N2[y|| XX:wu!X!jwfH
~s~ t[3
~s~ t[3
`%` :8i}8
`%` :8i}8
$F*`2Fv mpmX@o-3I, f8c!o`cGu!*
$F*`2Fv mpmX@o-3I, f8c!o`cGu!*
wY)Yh }^enxe;e@
wY)Yh }^enxe;e@
MBBgKUqUZ; RSzU: Ysmtfwwf$Ybs
MBBgKUqUZ; RSzU: Ysmtfwwf$Ybs
Gtm=Ud!=y wrw c;QZPP ^opoFo^FoSp Hlp/1/p/u/y
Gtm=Ud!=y wrw c;QZPP ^opoFo^FoSp Hlp/1/p/u/y
oZ T+zVZ e={Y{
oZ T+zVZ e={Y{
*j 70 YUG8G
*j 70 YUG8G
B7{~ Vr^x^
B7{~ Vr^x^
Zcmo&8j o|{i{
Zcmo&8j o|{i{
W) _/D/r/r
W) _/D/r/r
:* yeii
:* yeii
KD %+tt
KD %+tt
?4 xp||
?4 xp||
{S &#k&~z#
{S &#k&~z#
HC |)}
HC |)}
Z* dyy
Z* dyy
2{ s&M
2{ s&M
9HK3 8//
9HK3 8//
}] *w1x1 1j@)o@ZQ&}8@j w0obOWllR0u_
}] *w1x1 1j@)o@ZQ&}8@j w0obOWllR0u_
d3 E9Dg6 {r8{ )Gd(d
d3 E9Dg6 {r8{ )Gd(d
_Dx0x xLi^ &,Z|NA{wVN,Z
_Dx0x xLi^ &,Z|NA{wVN,Z
r~ cyt M7]Z0 2|VBjh
r~ cyt M7]Z0 2|VBjh
lfkPv 6twQ`o
lfkPv 6twQ`o
4]]qN?N
4]]qN?N
gr Wpbobᵇ
gr Wpbobᵇ
b{HD0|_ Untftᵇ
b{HD0|_ Untftᵇ
0x= kpvhvᵇ
0x= kpvhvᵇ
Fy f$OTTᵇ
Fy f$OTTᵇ
c1 :B0,z N5z
c1 :B0,z N5z
(F Hvo^: _7f
(F Hvo^: _7f
|1=d]wgdi y}
|1=d]wgdi y}
Xv !IZ %E2{yY K{:\
Xv !IZ %E2{yY K{:\
-A ^#X#
-A ^#X#
N$tk;t;~$~
N$tk;t;~$~
(:]:6(6
(:]:6(6
:_L XETE IHUHZH_ZH&U %d(h0h(hq(R
:_L XETE IHUHZH_ZH&U %d(h0h(hq(R
go^So
go^So
qzyL ]v[ Sp
qzyL ]v[ Sp
kZ(wb
&m`c?R XtQ KN?U1U
Y
Y
W
W
f
f
(Mrw e! Xh_Xy/
zmr8 `k) *-`=5
|jj{mjj
|jj{mjj
jH
jH
Z9Z 97
Z9Z 97
J~J [W!
J~J [W!
hv aT-
hv aT-
{({ svV
{({ svV
u6u {vu1v K}9V uR7P6
u6u {vu1v K}9V uR7P6
!/}QIq[XIP o/&(o&R :mqh77 wWvVYmWmXVeS
!/}QIq[XIP o/&(o&R :mqh77 wWvVYmWmXVeS
t$ }ZZᵃ
t$ }ZZᵃ
@q@ r1
@q@ r1
eGe #QQ
eGe #QQ
@/@ zz ]nDc LZEEvE|9
@/@ zz ]nDc LZEEvE|9
/6h^6OM
/6h^6OM
Q3NaHH )tHemttt=eS_
Q3NaHH )tHemttt=eS_
:n: 7:e POu &b& vTT
:n: 7:e POu &b& vTT
N2[y|| XX:wu!X!jwfH
N2[y|| XX:wu!X!jwfH
~s~ t[3
~s~ t[3
`%` :8i}8
`%` :8i}8
$F*`2Fv mpmX@o-3I, f8c!o`cGu!*
$F*`2Fv mpmX@o-3I, f8c!o`cGu!*
wY)Yh }^enxe;e@
wY)Yh }^enxe;e@
MBBgKUqUZ; RSzU: Ysmtfwwf$Ybs
MBBgKUqUZ; RSzU: Ysmtfwwf$Ybs
Gtm=Ud!=y wrw c;QZPP ^opoFo^FoSp Hlp/1/p/u/y
Gtm=Ud!=y wrw c;QZPP ^opoFo^FoSp Hlp/1/p/u/y
oZ T+zVZ e={Y{
oZ T+zVZ e={Y{
*j 70 YUG8G
*j 70 YUG8G
B7{~ Vr^x^
B7{~ Vr^x^
Zcmo&8j o|{i{
Zcmo&8j o|{i{
W) _/D/r/r
W) _/D/r/r
:* yeii
:* yeii
KD %+tt
KD %+tt
?4 xp||
?4 xp||
{S &#k&~z#
{S &#k&~z#
HC |)}
HC |)}
Z* dyy
Z* dyy
2{ s&M
2{ s&M
9HK3 8//
9HK3 8//
}] *w1x1 1j@)o@ZQ&}8@j w0obOWllR0u_
}] *w1x1 1j@)o@ZQ&}8@j w0obOWllR0u_
d3 E9Dg6 {r8{ )Gd(d
d3 E9Dg6 {r8{ )Gd(d
_Dx0x xLi^ &,Z|NA{wVN,Z
_Dx0x xLi^ &,Z|NA{wVN,Z
r~ cyt M7]Z0 2|VBjh
r~ cyt M7]Z0 2|VBjh
lfkPv 6twQ`o
lfkPv 6twQ`o
4]]qN?N
4]]qN?N
gr Wpbobᵇ
gr Wpbobᵇ
b{HD0|_ Untftᵇ
b{HD0|_ Untftᵇ
0x= kpvhvᵇ
0x= kpvhvᵇ
Fy f$OTTᵇ
Fy f$OTTᵇ
c1 :B0,z N5z
c1 :B0,z N5z
(F Hvo^: _7f
(F Hvo^: _7f
|1=d]wgdi y}
|1=d]wgdi y}
Xv !IZ %E2{yY K{:\
Xv !IZ %E2{yY K{:\
-A ^#X#
-A ^#X#
N$tk;t;~$~
N$tk;t;~$~
(:]:6(6
(:]:6(6
:_L XETE IHUHZH_ZH&U %d(h0h(hq(R
:_L XETE IHUHZH_ZH&U %d(h0h(hq(R
go^So
go^So
qzyL ]v[ Sp
qzyL ]v[ Sp
kZ(wb
&m`c?R XtQ KN?U1U
Y
Y
W
W
f
f
aR}tRIé
^TYXC@+ FP HT)OTH)OT xv2 B`[ KZQZ&q[n
kZ(wb
hfHF:IFysHs: f JJ% 9KK9?98v:
|jj{mjj
Y
TYStt31tAYG
|jj{mjj
jH
Y
TYStt31tAYG
jH
Z9Z 97
Y
TYStt31tAYG
Z9Z 97
J~J [W!
Y
TYStt31tAYG
J~J [W!
hv aT-
Y
TYStt31tAYG
hv aT-
{({ svV
W
TYStt31tAYG
{({ svV
u6u {vu1v K}9V uR7P6
W
TYStt31tAYG
u6u {vu1v K}9V uR7P6
!/}QIq[XIP o/&(o&R :mqh77 wWvVYmWmXVeS
W
TYStt31tAYG
!/}QIq[XIP o/&(o&R :mqh77 wWvVYmWmXVeS
4YI(Y-YkMpK A fz}V gIHg[guQ_
t$ }ZZᵃ
Y
TYStt31tAYG
t$ }ZZᵃ
@q@ r1
W
TYStt31tAYG
@q@ r1
eGe #QQ
W
TYStt31tAYG
eGe #QQ
{({ svV
W
TYStt31tAYG
{({ svV
@/@ zz ]nDc LZEEvE|9
f
TYStt31tAYG
@/@ zz ]nDc LZEEvE|9
/6h^6OM
f
TYStt31tAYG
/6h^6OM
Q3NaHH )tHemttt=eS_
f
TYStt31tAYG
Q3NaHH )tHemttt=eS_
I0IoQ$$tY f Ki23`5@(Y`YQ 4ia4
Q3NaHH )tHemttt=eS_
f
TYStt31tAYG
Q3NaHH )tHemttt=eS_
:n: 7:e POu &b& vTT
W
TYStt31tAYG
:n: 7:e POu &b& vTT
7278)HEE} u L`C9 zkX pQWj ]3c]d]YAy
N2[y|| XX:wu!X!jwfH
f
TYStt31tAYG
N2[y|| XX:wu!X!jwfH
m?_*m*?U@ZLs q g6B|(|~(C
~s~ t[3
Y
TYStt31tAYG
~s~ t[3
jr:wQ4i:Hwk { ymRN;obubo
`%` :8i}8
f
TYStt31tAYG
`%` :8i}8
hfHF:IFysHs: f JJ% 9KK9?98v:
$F*`2Fv mpmX@o-3I, f8c!o`cGu!*
Y
TYStt31tAYG
$F*`2Fv mpmX@o-3I, f8c!o`cGu!*
wY)Yh }^enxe;e@
W
TYStt31tAYG
wY)Yh }^enxe;e@
NbN%^t|Nt ? ([yx+[9U5Tk9kB S^xS
MBBgKUqUZ; RSzU: Ysmtfwwf$Ybs
f
TYStt31tAYG
MBBgKUqUZ; RSzU: Ysmtfwwf$Ybs
NVe\b%KAeAbf¹ F pK\ z 3KNs
Gtm=Ud!=y wrw c;QZPP ^opoFo^FoSp Hlp/1/p/u/y
W
TYStt31tAYG
Gtm=Ud!=y wrw c;QZPP ^opoFo^FoSp Hlp/1/p/u/y
m?_*m*?U@ZLs q g6B|(|~(C
oZ T+zVZ e={Y{
Y
TYStt31tAYG
oZ T+zVZ e={Y{
*j 70 YUG8G
Y
TYStt31tAYG
*j 70 YUG8G
B7{~ Vr^x^
Y
TYStt31tAYG
B7{~ Vr^x^
Zcmo&8j o|{i{
Y
TYStt31tAYG
Zcmo&8j o|{i{
W) _/D/r/r
Y
TYStt31tAYG
W) _/D/r/r
:* yeii
Y
TYStt31tAYG
:* yeii
KD %+tt
Y
TYStt31tAYG
KD %+tt
?4 xp||
Y
TYStt31tAYG
?4 xp||
{S &#k&~z#
Y
TYStt31tAYG
{S &#k&~z#
HC |)}
Y
TYStt31tAYG
HC |)}
Z* dyy
Y
TYStt31tAYG
Z* dyy
2{ s&M
Y
TYStt31tAYG
2{ s&M
9HK3 8//
W
TYStt31tAYG
9HK3 8//
}] *w1x1 1j@)o@ZQ&}8@j w0obOWllR0u_
f
TYStt31tAYG
}] *w1x1 1j@)o@ZQ&}8@j w0obOWllR0u_
jr:wQ4i:Hwk { ymRN;obubo
d3 E9Dg6 {r8{ )Gd(d
Y
TYStt31tAYG
d3 E9Dg6 {r8{ )Gd(d
_Dx0x xLi^ &,Z|NA{wVN,Z
f
TYStt31tAYG
_Dx0x xLi^ &,Z|NA{wVN,Z
oHcyFb_D² 7 g;nS nLEnunYNm
r~ cyt M7]Z0 2|VBjh
f
TYStt31tAYG
r~ cyt M7]Z0 2|VBjh
=D=(Lee$G ] B%bt `o,`_`FEy
r~ cyt M7]Z0 2|VBjh
f
TYStt31tAYG
r~ cyt M7]Z0 2|VBjh
c}D7EVfS³ V \M/enZkS
r~ cyt M7]Z0 2|VBjh
f
TYStt31tAYG
r~ cyt M7]Z0 2|VBjh
ejetlIhI $ %tMt fet
lfkPv 6twQ`o
f
TYStt31tAYG
lfkPv 6twQ`o
E0E022`⁴ S @9C1+Chb*
4]]qN?N
W
TYStt31tAYG
4]]qN?N
:* yeii
W
TYStt31tAYG
:* yeii
/wzkj((t : cw XSGZFd8BFSd@
gr Wpbobᵇ
W
TYStt31tAYG
gr Wpbobᵇ
b{HD0|_ Untftᵇ
W
TYStt31tAYG
b{HD0|_ Untftᵇ
0x= kpvhvᵇ
W
TYStt31tAYG
0x= kpvhvᵇ
Fy f$OTTᵇ
W
TYStt31tAYG
Fy f$OTTᵇ
g/BMb/I/z/Q⁵ \ iyziBbZop gI9t
c1 :B0,z N5z
W
TYStt31tAYG
c1 :B0,z N5z
(F Hvo^: _7f
Y
TYStt31tAYG
(F Hvo^: _7f
(^(:k&&x @ =l&PMhnM$
|1=d]wgdi y}
W
TYStt31tAYG
|1=d]wgdi y}
777(:42a4 Y miIl dOKdLd5-u
lfkPv 6twQ`o
f
TYStt31tAYG
lfkPv 6twQ`o
pzp?o8d-d 4 620N TpRTUTwd=
lfkPv 6twQ`o
f
TYStt31tAYG
lfkPv 6twQ`o
_r_{pSd3S , -AT{ KZKRbZ[
lfkPv 6twQ`o
f
TYStt31tAYG
lfkPv 6twQ`o
9r9oE|JrE j 3`}ζ z1xzhz$jP
lfkPv 6twQ`o
f
TYStt31tAYG
lfkPv 6twQ`o
t!t%K,pOO M zZs{trroW
lfkPv 6twQ`o
f
TYStt31tAYG
lfkPv 6twQ`o
Nx9X`x!X@ o #C-# y*{ 1Zx101b#P
Xv !IZ %E2{yY K{:\
Y
TYStt31tAYG
Xv !IZ %E2{yY K{:\
,:)R:*:y:Z⁶ 5 @``J O )Xd
-A ^#X#
Y
TYStt31tAYG
-A ^#X#
N$tk;t;~$~
Y
TYStt31tAYG
N$tk;t;~$~
(:]:6(6
Y
TYStt31tAYG
(:]:6(6
:_L XETE IHUHZH_ZH&U %d(h0h(hq(R
f
TYStt31tAYG
:_L XETE IHUHZH_ZH&U %d(h0h(hq(R
H*NKF0O*80L⁶ & Kq$5Kj 1 YQf
go^So
f
TYStt31tAYG
go^So
CFCboaK\ f MDK!D L@=q@tp
lfkPv 6twQ`o
f
TYStt31tAYG
lfkPv 6twQ`o
UEU8UtQQK b OBJL G k?ocY 1PRO
qzyL ]v[ Sp
f
TYStt31tAYG
qzyL ]v[ Sp
jJjgjKeHH , {oi5 A +\Nkk
lfkPv 6twQ`o
f
TYStt31tAYG
lfkPv 6twQ`o

À ~Zv2Vv &V i/û| oqoR

fAmgen collaboration; BeiGene has China commercial rights. WEnsem collaboration; BeiGene has global rights. YDualityBio collaboration; BeiGene has global clinical, manufacturing, and commercialization rights. ALeads Biolabs collaboration; BeiGene has global research, development, and manufacturing rights, and exclusive commercialization rights outside of China. _Zymeworks/Jazz collaboration; BeiGene has exclusive development and commercialization rights in Asia (except Japan), Australia, and New Zealand. uAmgen collaboration; BeiGene has development and commercialization rights in China. pIn combination with Zanubrutinib. HMay include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor.

Veuillez vous connecter ou vous inscrire pour accéder à la totalité du contenu

S’inscrire

Déjà inscrit(e) ?  Se connecter